Stony Brook Experts

an online search tool for members of the media to identify experts at Stony Brook

Search experts:

or

Browse experts:

View all departments View all topics View all experts Close
Michael L. Pearl Professor and Director of Division of Gynecological Oncology, Vice Chairman of Research and Faculty Development, Director of Women's Cancer services Obstetrics Gynecology and Reproductive Medicine School of Medicine

Contact Information

T9-065 Health Sciences Center

Stony Brook, 11794

631/444-2989

Biography

Michael Pearl’s research interests are ovarian cancer, uterine cancer, and general gynecologic oncology. In addition to his clinical activities, he is the chairman of Stony Brook University’s Committee (B) on Research in Human Subjects. He is also the Principal Investigator at Stony Brook Medicine for NRG Oncology, a National Cancer Institute-funded cooperative research group dedicated to promoting excellence in the quality and integrity of scientific research.

Education

  • Fellowship, University of Michigan Hospitals
  • MD and Residency, University of California

Research Grants

Award Start End Sponsor Type Amount Status
OPIOID INDUCED POSTOPERATIVE BOWEL DYSFUNCTION/POSTOPERATIVE ILEUS - ADOLOR CORP 2001-11-16T00:00:00 2005-11-23T00:00:00 Omnicare Clinical Research Nonfederal 4200 Closed
PROVIDING CANCEROUS CERVICAL TISSUE SAMPLES 2004-09-22T00:00:00 2006-08-02T00:00:00 Cytyc Corporation Nonfederal 4250 Closed
BRN #102 WEEKLY TOPOTECAN STUDY IN OVARIAN CARCINOMA 1999-03-12T00:00:00 2001-04-19T00:00:00 Brookview Research Incorporated Nonfederal 5000 Closed
SBIR: Cancer Progenitor Cell Markers 2009-09-23T00:00:00 2014-05-06T00:00:00 Vitatex Inc Nonfederal 508111 Closed
Gynecologic Oncology Group Support - CTSU - 70 Study 213 & 218 2004-04-01T00:00:00 2013-03-31T00:00:00 Gynecologic Oncology Group Nonfederal 1040370.1 Closed
Phase I Fixed-Dose Rate Gemcitabine + Carboplatin in Platinum-Sensitive Late-Relapsed Ovarian Cancer, Fallopian Tube Cancer or Primary Peritoneal Cancer 2003-03-19T00:00:00 2005-05-17T00:00:00 Eli Lilly and Company Nonfederal 5625 Closed
Phase II Study of Weekly Docetaxel for Patients with Advanced or Recurrent Cancer of the Cervix (GIA-13041) 2002-12-11T00:00:00 2008-12-08T00:00:00 Aventis Pharmaceuticals Nonfederal 50203.44 Closed
GYNECOLOGIC ONCOLOGY GROUP SUPPORT 1989-07-01T00:00:00 2004-07-31T00:00:00 Gynecologic Oncology Group Nonfederal 885451.8 Closed
A Randomized Phase III Trial of Gemzar versus Doxil with Crossover Treatment Option for Patients with Platinum Refractory Ovarian Fallopian Tube or Primary Peritoneal Cancer Undergoing Second or Third Line Chemotherapy 2003-03-19T00:00:00 2005-10-22T00:00:00 Eli Lilly and Company Nonfederal 5625 Closed
PROTOCOL 2, BRN 2001: WEEKLY TOPOTECAN & PACLITAXEL AS 2ND OR 3RD LINE THERAPY FOR ADVANCED EPITHELIAL OVARIAN CANCER 1999-03-12T00:00:00 2001-04-19T00:00:00 Brookview Research Incorporated Nonfederal 9000 Closed
Tissue Procurement Study 2003-06-24T00:00:00 2005-09-03T00:00:00 Precision Therapeutics Incorporated Nonfederal 9050 Closed
Phase II trial of Liposomal Doxorubicin Consolidation Therapy after Platinum/Paclitaxel-Based Chemotherapy for patients with Stage III of IV Ovarian/Peritoneal Cancer 2001-08-03T00:00:00 2007-02-14T00:00:00 Alza Corporation Nonfederal 34500 Closed
Gynecologic Oncology Group 2010-04-01T00:00:00 2018-03-15T00:00:00 Gynecologic Oncology Group Nonfederal 629115.59 Approved
NRG Oncology Foundation Contract 2014-03-01T00:00:00 2018-06-10T00:00:00 NRG Oncology Foundation Inc Nonfederal 219970 Approved
Woman to Woman at Stony Brook University Cancer Center, a program of Ovarian Cancer Research Fund 2014-07-01T00:00:00 2018-06-30T00:00:00 Ovarian Cancer Research Fund Nonfederal 50000 Approved
Biotech: Blood Assays to Analyze Tumor Heterogeneity and Drug Resistance 2014-09-15T00:00:00 2016-09-14T00:00:00 Vitatex Inc Nonfederal 81865 Closed
SBIR: Vita-Cap Tube to Preserve Circulating Tumor Cells in Blood (Phase I & II) 2015-09-11T00:00:00 2018-06-10T00:00:00 Vitatex Inc Nonfederal 398934 Approved

Publications

  1. Author Article Obstetrical & Gynecological Survey Laparoscopy Compared With Laparotomy for Comprehensive Surgical Staging of Uterine Cancer: Gynecologic Oncology Group Study LAP2 2010 65 8 503 - 505
  2. Author Article Gynecologic Oncology Clinical significance of circulating tumor cells detected by an invasion assay in peripheral blood of patients with ovarian cancer 2009 112 1 185 - 191
  3. Author Article International Journal of Gynecological Pathology Malignant Uterine Perivascular Epithelioid Cell Tumor, Pelvic Lymph Node Lymphangioleiomyomatosis, and Gynecological Pecomatosis in a Patient With Tuberous Sclerosis 2008 27 1 86 - 90
  4. Author Article International Journal of Gynecological Pathology Sertoliform Endometrioid Carcinoma of the Endometrium With Dual Immunophenotypes for Epithelial Membrane Antigen and Inhibin ?? 2007 26 3 291 - 297
  5. Author Article Gynecologic and Obstetric Investigation Pilot Phase 2 Trial of 4 Months of Maintenance Pegylated Liposomal Doxorubicin in Patients with Advanced Ovarian Cancer after Complete Response to Platinum and Paclitaxel-Based Chemotherapy 2007 63 1 1 - 6
  6. Author Article International Journal of Gynecological Pathology Carcinomas of Ovary and Lung With Clear Cell Features 2007 26 2 134 - 140
  7. Author Article Cancer Research Activation of EDTA-Resistant Gelatinases in Malignant Human Tumors 2006 66 20 9977 - 9985
  8. Author Article International Journal of Gynecological Pathology A High-Grade Uterine Leiomyosarcoma With Human Chorionic Gonadotropin Production 2006 25 3 257 - 261
  9. Author Article The Journal of Bone and Joint Surgery Arthroscopic Release and Latissimus Dorsi Transfer for Shoulder Internal Rotation Contractures and Glenohumeral Deformity Secondary to Brachial Plexus Birth Palsy 2006 88 3 564 - 574

Video

Watch video